정상 산모와 전자간증 산모의 태반에서 Adenosine 수용체의 발현 양상

키워드

참고문헌 (39)

1. "Modulators of adenosine uptake, release, and inactivation", pp.129~148 (1997), New York: Wiley-Liss;
2. "Influences of adenosine on the fetus and newborn", 74, pp.160~171 (2001)
3. "Ohisaro JJ. Regulatory functions of adenosine. Med Biol 1987"
4. "Schrader J. Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol 1986", pp.173~80
5. "Doany M. Role of plasma adenosine in breathing responses to hypoxia in fetal sheep. J Dev Physiol 1991", pp.81~5
6. "Changes in plasma adenosine concentration during normal pregnancy", 50, pp.145~148 (2000)
7. "Araki T. Relationship between plasma adenosine concentration and breathing movements in growth-retarded fetuses. Am J Obstet Gynecol 1994", pp.701~6
8. "Pearson JD. Metabolism of adenine nucleotides in human blood. Circ Res 1989", pp.531~7
9. "Berne RM. Hormonal role of adenosine in maintaining patency of the ductus arteriosus in fetal lambs. Ann Surg 1985", pp.223~30
10. "Lagercrantz H. Adenosine concentration in 것으로 미루어 전자간증의 병태생리에 중요한 역할을 할 것으로 사료된다. 태반에서 저산소증과 관련된 중요 요소로 잘 알려진 것은 hypoxia-inducible transcription factor 1α와 1β HIF 1α와 1β 이며 전자간증 산모에서 매우 증가되는 것으로 알려져 있다.36 37 혈관 생성의 중요 요소로 알려져 있는 VEGF도 저산소증 상태에서 발현이 증가하며 HIF에 의하여 조절이 되는 것으로 알려져 있는데 38 전자간증 산모의 태반에서 발현이 증가한다고 보고되어져 있다.39 Merighi 등은 저산소증 상태에 있는 암세포 조직에 Adenosine A3 수용체에 대한 길항제를 투여한 실험을 통하여 이 수용체가 HIF를 통한 VEGF의 발현에 관여한다는 보고를 하였다.40 이런 연구들은 전자간증 산모의 태반에서 A3 수용체의 발현이 증가한다는 본 연구의 결과와 일치하는 소견이다.본 연구의 결과를 볼 때 전자간증 산모의 태반에서 A3 수용체가 증가하는 것은 아마도 저산소증에"
11. "and lactate in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol 1989", eco(moides dl), pp.996~1001
12. "et al. Plasma adenosine concentration in appropriate- and small-for- gestational-age fetuses. Am J Obstet Gynecol 1994", pp.684~8
13. "Plasma adenosine levels increase in women with normal pregnancies", 182, pp.1200~1203 (2000)
14. "Recent knowledge on mechanisms underlying development of preeclampsia", 124, pp.21~24 (2004)
15. "Hypoxia stimulates cytokine production by villous explants from the human placenta", 82, pp.1582~1588 (1997)
16. "Activation of adenosine receptors inhibits tumor necrosis factor-? mRNA stability and p38 activity", 497, pp.87~95 (2004)
17. "Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells", 103, pp.1391~1397 (2004)
18. "Adenosine receptor subtypes: Characterization and therapeutic regulation", 581, pp.581~606 (1995)
19. "Structure and function of adenosine receptors and their genes", 362, pp.364~374 (2000)
20. "Rivkees SA. Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol 1991", pp.1037~48
21. "Civelli O. Molecular cloning and characterization of an adenosine receptor", pp.7432~6
22. "et al. The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO J 1991", pp.1677~82
23. "et al. RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun 1990", pp.1169~78
24. "et al. Molecular cloning of the rat A2 adenosine receptor Selective co-expression with D2 dopamine receptors in rat striatum. Brain Res Mol Brain Res 1992"
25. "Reppert SM. RFL9 encodes an A2b-adenosine receptor. Mol Endocrinol 1992", pp.1598~604
26. "Bruns RF. Structure- Activity Relationships of Adenosine A1 and A2 Receptors. In Adenosine and Adenosine Receptors" (1990), Humana Press
27. "Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation", 100, pp.2849~2857 (1997)
28. "An A3-subtype adenosine receptor is highly expressed in rat vascular smooth muscle cells: Its role in attenuating adenosine-induced increase in cAMP", 54, pp.243~252 (1997)
29. "Receptors for purines and pyrimidines", 50, pp.413~492 (1998)
30. "The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine", 57, pp.2602~2605 (1997)
31. "International Union of Pharmacology. Part XXV. Nomenclature andclassification of adenosine receptors", 53, pp.527~552 (2001)
32. "Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells", 10, pp.5895~5901 (2004)
33. "Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype", 44, pp.649~654 (2004)
34. "Mast cell mediated stimulation of angiogenesis: cooperative interaction between A2B and A3 adenosine receptors", 92, pp.485~492 (2003)
35. "Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta", 63, pp.559~569 (2000), Conrad KP. Expression
36. "Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia", 64, pp.499~506 (2001)
37. "Targeting HIF-1 for cancer therapy", 3, pp.721~732 (2003)
38. "Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1", 94, pp.1561~1567 (1999)
39. Merighi S, "Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells", 72, pp.19~31 (2006)

관련 논문AI추천